Mutations at the domain interface of Gsα impair receptor-mediated activation by altering receptor and guanine nucleotide binding

被引:47
作者
Grishina, G [1 ]
Berlot, CH [1 ]
机构
[1] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA
关键词
D O I
10.1074/jbc.273.24.15053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G protein alpha subunits consist of two domains, a GTPase domain and a helical domain. Receptors activate G proteins by catalyzing replacement of GDP, which is buried between these two domains, with GTP, Substitution of the homologous alpha(i2) residues for four alpha(s) residues in switch III, a region that changes conformation upon GTP binding, or of one nearby helical domain residue decreases the ability of alpha(s) to be activated by the beta-adrenergic receptor and by aluminum fluoride. Both sets of mutations increase the affinity of alpha(s) for the beta-adrenergic receptor, based on an increased amount of high affinity binding of the beta-adrenergic agonist, isoproterenol, The mutations also decrease the rate of receptor-mediated activation and disrupt the ability of the beta-adrenergic receptor to increase the apparent affinity of alpha(s) for the GTP analog, guanosine 5'-O-(3-thiotriphosphate). Simultaneous replacement of the helical domain residue and one of the four switch III residues with the homologous alpha(i2) residues restores normal receptor-mediated activation, suggesting that the defects caused by mutations at the domain interface are due to altered interdomain interactions. These results suggest that interactions between residues across the domain interface are involved in two key steps of receptor-mediated activation, promotion of GTP binding and subsequent receptor-G protein dissociation.
引用
收藏
页码:15053 / 15060
页数:8
相关论文
共 40 条
[1]  
BERSTEIN G, 1992, J BIOL CHEM, V267, P8081
[2]   SELECTION OF A VARIANT LYMPHOMA CELL DEFICIENT IN ADENYLATE CYCLASE [J].
BOURNE, HR ;
COFFINO, P ;
TOMKINS, GM .
SCIENCE, 1975, 187 (4178) :750-752
[3]  
BOURNE HR, 1981, MOL PHARMACOL, V20, P435
[4]  
BRANDT DR, 1986, J BIOL CHEM, V261, P1656
[5]  
CASSEL D, 1977, J CYCLIC NUCL PROT, V3, P11
[6]  
CODINA J, 1994, J BIOL CHEM, V269, P29339
[7]   STRUCTURES OF ACTIVE CONFORMATIONS OF G(I-ALPHA-1) AND THE MECHANISM OF GTP HYDROLYSIS [J].
COLEMAN, DE ;
BERGHUIS, AM ;
LEE, E ;
LINDER, ME ;
GILMAN, AG ;
SPRANG, SR .
SCIENCE, 1994, 265 (5177) :1405-1412
[8]   HIGH-RESOLUTION EPITOPE MAPPING OF HGH-RECEPTOR INTERACTIONS BY ALANINE-SCANNING MUTAGENESIS [J].
CUNNINGHAM, BC ;
WELLS, JA .
SCIENCE, 1989, 244 (4908) :1081-1085
[9]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[10]  
FLORIO VA, 1989, J BIOL CHEM, V264, P3909